CYTK
Price
$33.16
Change
-$0.75 (-2.21%)
Updated
Jun 27 closing price
Capitalization
3.96B
32 days until earnings call
TRAW
Price
$1.43
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
7.96M
Interact to see
Advertisement

CYTK vs TRAW

Header iconCYTK vs TRAW Comparison
Open Charts CYTK vs TRAWBanner chart's image
Cytokinetics
Price$33.16
Change-$0.75 (-2.21%)
Volume$2.35M
Capitalization3.96B
Traws Pharma
Price$1.43
Change-$0.00 (-0.00%)
Volume$74.1K
Capitalization7.96M
CYTK vs TRAW Comparison Chart in %
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. TRAW commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a StrongBuy and TRAW is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (CYTK: $33.16 vs. TRAW: $1.43)
Brand notoriety: CYTK and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 130% vs. TRAW: 5%
Market capitalization -- CYTK: $3.96B vs. TRAW: $7.96M
CYTK [@Biotechnology] is valued at $3.96B. TRAW’s [@Biotechnology] market capitalization is $7.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, both CYTK and TRAW are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while TRAW’s TA Score has 3 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 3 bearish.
  • TRAW’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than TRAW.

Price Growth

CYTK (@Biotechnology) experienced а +2.25% price change this week, while TRAW (@Biotechnology) price change was -14.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

CYTK is expected to report earnings on Jul 31, 2025.

TRAW is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.96B) has a higher market cap than TRAW($7.96M). CYTK YTD gains are higher at: -29.507 vs. TRAW (-83.896). TRAW has higher annual earnings (EBITDA): -24.89M vs. CYTK (-513.62M). CYTK has more cash in the bank: 938M vs. TRAW (15.9M). CYTK has higher revenues than TRAW: CYTK (19.2M) vs TRAW (227K).
CYTKTRAWCYTK / TRAW
Capitalization3.96B7.96M49,768%
EBITDA-513.62M-24.89M2,063%
Gain YTD-29.507-83.89635%
P/E RatioN/AN/A-
Revenue19.2M227K8,458%
Total Cash938M15.9M5,899%
Total Debt791MN/A-
FUNDAMENTALS RATINGS
CYTK vs TRAW: Fundamental Ratings
CYTK
TRAW
OUTLOOK RATING
1..100
1598
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6366
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (28) in the Biotechnology industry is significantly better than the same rating for CYTK (100). This means that TRAW’s stock grew significantly faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (84) in the Biotechnology industry is in the same range as TRAW (100). This means that CYTK’s stock grew similarly to TRAW’s over the last 12 months.

CYTK's SMR Rating (100) in the Biotechnology industry is in the same range as TRAW (100). This means that CYTK’s stock grew similarly to TRAW’s over the last 12 months.

CYTK's Price Growth Rating (63) in the Biotechnology industry is in the same range as TRAW (66). This means that CYTK’s stock grew similarly to TRAW’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for TRAW (100). This means that CYTK’s stock grew significantly faster than TRAW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKTRAW
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 19 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HST15.760.05
+0.32%
Host Hotels & Resorts
AVA37.64-0.08
-0.21%
Avista Corp
CLDI0.22-0.01
-2.31%
Calidi Biotherapeutics
IMTX5.43-0.16
-2.86%
Immatics NV
THM0.86-0.04
-4.04%
International Tower Hill Mines Ltd

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IMVT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-2.21%
IMVT - CYTK
48%
Loosely correlated
-1.77%
IDYA - CYTK
48%
Loosely correlated
-4.13%
KRYS - CYTK
46%
Loosely correlated
-2.60%
ROIV - CYTK
44%
Loosely correlated
-1.81%
BEAM - CYTK
43%
Loosely correlated
-1.98%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with RAPT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then RAPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
N/A
RAPT - TRAW
46%
Loosely correlated
-13.36%
SLGL - TRAW
46%
Loosely correlated
-0.81%
MDGL - TRAW
39%
Loosely correlated
N/A
CYTK - TRAW
36%
Loosely correlated
-2.21%
AVXL - TRAW
35%
Loosely correlated
-0.94%
More